Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Fluorescence Diagnosis and Photodynamic Therapy of Skin Diseases

Atlas and Handbook
BuchGebunden
128 Seiten
Englisch
Springererschienen am17.06.2003
The main part of the book focuses on the clinical aspects giving detailed descriptions on skin tumor detection as well as photodynamic treatment of selected diseases (solar keratoses, basal cell carcinomas, squamous cell carcinomas, Bowen's disease, psoriasis lesions, etc.).mehr
Verfügbare Formate
BuchGebunden
EUR160,49
BuchKartoniert, Paperback
EUR160,49
E-BookPDF1 - PDF WatermarkE-Book
EUR149,79

Produkt

KlappentextThe main part of the book focuses on the clinical aspects giving detailed descriptions on skin tumor detection as well as photodynamic treatment of selected diseases (solar keratoses, basal cell carcinomas, squamous cell carcinomas, Bowen's disease, psoriasis lesions, etc.).
Details
ISBN/GTIN978-3-211-83827-3
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2003
Erscheinungsdatum17.06.2003
Seiten128 Seiten
SpracheEnglisch
Gewicht708 g
IllustrationenVII, 128 p.
Artikel-Nr.10526966
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Introduction and Historical Landmarks - Definition of the Photodynamic Action - Optimum Photosensitizing Agent for Photodynamic Action - Definition of Fluorescence Detection with ALA- Induced Porphyrins (FDAP) - Mechanisms of Action in PDT d-Aminolevulinic Acid (ALA) - Chemistry of ALA and ALA Methylester (ALA) - Metabolism of ALA - Pharmacodynamics of ALA Light Used in FDAP and PDT Unresolved Issues ind FDAP and PDT Fluorescence Detection of ALA-induced Porphyrins (FDAP) - FDAP: Evaluation of the ALA-Induced Fluoresence in Skin Diseases Ex vivo - Investigations on ALA-induced Porphyrins - Porphyrin Accumulation in Cells (in vitro) - Porphyrin Accumulation in Skin Tumors, Colon and Bronchial Carcinomas after Administration of ALA (ex vivo) In vivo - Investigations on ALA-Induced Porphyrin/FDAP - FDAP: Kinetics of ALA-induced Porphyrins in Human Cutaneous Tumors, Psoriasis Lesions and Normal Skin - FDAP: Kinetics of PorphyrinAccumulation in Solar Keratoses: ALA versus ALA Methylester - FDAP: use of the in vivo - Fluorescence for Surgical Planning - FDAP: Evaluation of the Optimum Photosensitizing Substance or its Prodrug - FDAP: Evaluation of the Optimum Exciting Light Source - FDAP: Correlation of in vivo - Tumor Fluorescence and Histopathology - FDAP: Course of FDAP in Relation to the Number of PDT-Sessions The Clinical Use of FDAP - FDAP in Clinically Well-defined Tumors - FDAP in Clinically Ill-defined Lesions - FDAP in Pretreated or Damaged Skin - Limitations of FDAP - Usefulness of FDAP in Guiding Tumor Therapies Photodynamic Therapy in Cutaneous Diseases - PDT: Evaluation of the Efficacy in Solar Keratoses - PDT: Evaluation of the Efficacy in Bowen`s Disease - PDT: Evaluation of the Efficacy in Basal Cell Carcinoma - PDT: Evaluation of the Efficacy Sqamous Cell Carcinoma - PDT: Evaluation of the Efficacy in Psoriatric Lesions - PDT: Evaluation ofthe Efficacy in Selected Cutaneous Diseases - PDT in Skin Cancers and Precanceroses Others than Discussed Above - PDT in Tumors of the Oral Mucosa - PDT in Non-neoplastic Skin Diseases - PDT in Non-dermatological Indications - PDT: Evaluation of the Optimum Photosensitizing Substance or its Prodrug - PDT: Evaluation of the Optimum Exciting Light Source General Discussion - FDAP: Indications and Limits - PDT: Indications and Limits - Safety and Tolerability of ALA-PDT - Regulatory Affairs Concerning Aminolevulinic Acid - Regulatory Affairs Concerning Aminolevulinic Acid Methylester Conclusion Summarymehr